
Moderna’s New Lower-Dose COVID-19 Vaccine Approved by FDA
By Stephanie Brown HealthDay Reporter WEDNESDAY, June 4, 2025 The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2. The new vaccine (mNexspike [COVID-19 Vaccine, mRNA]) represents a significant step forward in the development of next-generation coronavirus vaccines, the Associated…